BIONANO GENOMICS INC (BNGO) Stock Price & Overview
NASDAQ:BNGO • US09075F4046
Current stock price
The current stock price of BNGO is 1.16 USD. Today BNGO is up by 0.87%. In the past month the price increased by 0.87%. In the past year, price decreased by -60%.
BNGO Key Statistics
- Market Cap
- 11.809M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.76
- Dividend Yield
- N/A
BNGO Stock Performance
BNGO Stock Chart
BNGO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BNGO. When comparing the yearly performance of all stocks, BNGO is a bad performer in the overall market: 92.02% of all stocks are doing better.
BNGO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNGO. BNGO may be in some trouble as it scores bad on both profitability and health.
BNGO Earnings
On March 23, 2026 BNGO reported an EPS of -0.03 and a revenue of 7.95M. The company beat EPS expectations (97.9% surprise) and missed revenue expectations (-0.74% surprise).
BNGO Forecast & Estimates
9 analysts have analysed BNGO and the average price target is 5.61 USD. This implies a price increase of 383.62% is expected in the next year compared to the current price of 1.16.
For the next year, analysts expect an EPS growth of 23.52% and a revenue growth 24.27% for BNGO
BNGO Groups
Sector & Classification
BNGO Financial Highlights
Over the last trailing twelve months BNGO reported a non-GAAP Earnings per Share(EPS) of -4.76. The EPS increased by 94.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.81% | ||
| ROE | -77.49% | ||
| Debt/Equity | 0.07 |
BNGO Ownership
BNGO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.09 | 175.844B | ||
| DHR | DANAHER CORP | 21.38 | 128.36B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 125.6 | 41.316B | ||
| A | AGILENT TECHNOLOGIES INC | 16.48 | 32.069B | ||
| WAT | WATERS CORP | 19.9 | 28.367B | ||
| IQV | IQVIA HOLDINGS INC | 12.78 | 27.506B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.27 | 25.047B | ||
| ILMN | ILLUMINA INC | 22.49 | 17.992B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 30.04 | 17.541B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.88 | 13.242B | ||
| RVTY | REVVITY INC | 15.22 | 9.38B | ||
| TECH | BIO-TECHNE CORP | 22.9 | 8.245B | ||
| CRL | CHARLES RIVER LABORATORIES | 14.27 | 7.835B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BNGO
Company Profile
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 98 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Company Info
IPO: 2018-08-01
BIONANO GENOMICS INC
9540 Towne Centre Drive, Suite 100
San Diego CALIFORNIA 92121 US
CEO: R. Erik Holmlin
Employees: 98
Phone: 18588887600
BIONANO GENOMICS INC / BNGO FAQ
Can you describe the business of BIONANO GENOMICS INC?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 98 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Can you provide the latest stock price for BIONANO GENOMICS INC?
The current stock price of BNGO is 1.16 USD. The price increased by 0.87% in the last trading session.
What is the dividend status of BIONANO GENOMICS INC?
BNGO does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNGO stock?
BNGO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for BNGO stock?
9 analysts have analysed BNGO and the average price target is 5.61 USD. This implies a price increase of 383.62% is expected in the next year compared to the current price of 1.16.
Can you provide the sector and industry classification for BIONANO GENOMICS INC?
BIONANO GENOMICS INC (BNGO) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Is BIONANO GENOMICS INC (BNGO) expected to grow?
The Revenue of BIONANO GENOMICS INC (BNGO) is expected to grow by 24.27% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.